These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 8982737
41. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome? Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG. Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948 [Abstract] [Full Text] [Related]
43. Adult height in girls with Turner syndrome treated from before 6 years of age with a fixed per kilogram GH dose. Wasniewska M, Aversa T, Mazzanti L, Guarneri MP, Matarazzo P, De Luca F, Lombardo F, Messina MF, Valenzise M. Eur J Endocrinol; 2013 Oct; 169(4):439-43. PubMed ID: 23904278 [Abstract] [Full Text] [Related]
44. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. Stephure DK, Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab; 2005 Jun; 90(6):3360-6. PubMed ID: 15784709 [Abstract] [Full Text] [Related]
45. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. J Clin Endocrinol Metab; 1998 May; 83(5):1462-6. PubMed ID: 9589639 [Abstract] [Full Text] [Related]
50. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, François I, Du Caju M, Maes M, De Schepper J, Belgian Study Group for Pediatric Endocrinology. J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282 [Abstract] [Full Text] [Related]
51. Effect of growth hormone therapy on adult height of children with Turner syndrome. Hsu PY, Tung YC, Tsai WY, Lee JS, Hsiao PH. J Formos Med Assoc; 2008 Sep; 107(9):704-9. PubMed ID: 18796360 [Abstract] [Full Text] [Related]
54. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421 [Abstract] [Full Text] [Related]
55. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO, KIGS International Board. Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150 [Abstract] [Full Text] [Related]
56. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome. Ranke MB, Lindberg A, Brosz M, Kaspers S, Loftus J, Wollmann H, Kołtowska-Haggstrom M, Roelants M. Horm Res Paediatr; 2012 Jan; 78(1):8-17. PubMed ID: 22832697 [Abstract] [Full Text] [Related]
57. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD. Hasegawa Y, Ariyasu D, Izawa M, Igaki-Miyamoto J, Fukuma M, Hatano M, Yagi H, Goto M. Endocr J; 2017 Feb 27; 64(2):221-227. PubMed ID: 27916781 [Abstract] [Full Text] [Related]
58. Final height and long-term outcome after growth hormone therapy in Turner syndrome: results of a German multicentre trial. Attanasio A, James D, Reinhardt R, Rekers-Mombarg L. Horm Res; 1995 Feb 27; 43(4):147-9. PubMed ID: 7750918 [Abstract] [Full Text] [Related]